ChartRow logo
ChartRow
Stocks and ETFs
Calculator

If you invested in in

A $1,000 investment in Quest Diagnostics Incorporated (DGX) in January 2016 would be worth $3,802 as of June 2026 with dividends reinvested13.8% a year. Use the dropdowns above to try any amount, ticker, or starting month back to December 1996.

Worth today
$3,802
Multiple
3.8×
Annualized
13.8%/yr
Same $ in SPY
$4,503

Growth of $1,000 in DGX since January 2016

dividends reinvested · monthly
100020003000
201620212026

Quest Diagnostics Incorporated (DGX). Total return approximated via dividend- and split-adjusted closes (dividends reinvested, no taxes or fees). Not investment advice.

$1,000 invested in DGX, by starting year

Invested inWorth today (div. reinvested)Price-onlyMultipleAnnualized
1996$75,638$53,90675.6×15.8%
1997$72,636$51,76672.6×15.7%
1998$68,813$49,04268.8×16.1%
1999$60,410$43,05360.4×16.2%
2000$33,648$23,98033.6×14.3%
2001$11,053$7,87711.1×9.9%
2002$8,255$5,8838.3×9.1%
2003$10,636$7,58010.6×10.7%
2004$6,716$4,7966.7×8.9%
2005$5,949$4,2785.9×8.7%
2006$5,705$4,1245.7×8.9%
2007$5,345$3,8845.3×9.0%
2008$5,658$4,1435.7×9.9%
2009$5,595$4,1305.6×10.4%
2010$4,923$3,6614.9×10.2%
2011$4,777$3,5794.8×10.7%
2012$4,644$3,5094.6×11.3%
2013$4,592$3,5174.6×12.1%
2014$4,965$3,8825.0×13.8%
2015$3,591$2,8683.6×11.9%
2016$3,802$3,1043.8×13.8%
2017$2,662$2,2172.7×11.0%
2018$2,272$1,9262.3×10.3%
2019$2,696$2,3332.7×14.4%
2020$2,084$1,8422.1×12.2%
2021$1,747$1,5781.7×11.0%
2022$1,642$1,5101.6×12.0%
2023$1,464$1,3731.5×12.0%
2024$1,657$1,5871.7×23.9%
2025$1,278$1,2501.3×19.8%

Methodology

Investments are assumed made at the first trading day's close of the chosen year. "Dividends reinvested" uses split- and dividend-adjusted closes (a standard total-return approximation; taxes and fees excluded). "Price-only" uses split-adjusted closes. DGX data begins December 1996; values as of June 2026 and refresh daily. Past performance does not predict future returns; not investment advice.

See the live DGX chart and fundamentals on the DGX quote page or compare with the same investment in SPY.